Suren Azad Ramadhan

Dr. Suren Azad Ramadhan

Pharmacy, Knowledge University, Erbil, Arbīl, Iraq
B.Sc. Pharmacy, M.Sc. Pharmaceutics, PhD. Candidate

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2025 in OMICS: A Journal of Integrative Biology
Verified
Journal Article
Closed access
Suren Azad RamadhanSuren Azad Ramadhan
Suren Azad Ramadhan
DADiyar Salahuddin Ali
Diyar Salahuddin Ali
Drug delivery innovation is an important pillar of systems pharmacology wherein nanotechnology offers significant prospects. This expert review examines and unpacks how core–shell nanoparticles (NPs) could revolutionize drug delivery systems and play a key role in advancing personalized and precision medicine. Core–shell NPs have gained attention as flexible tools for drug delivery due to their distinct structure, which features a core material enclosed by a protective shell. This setup offers multiple benefits, such as effective drug encapsulation, shielding the drug from degradation, and allowing for controlled release. Accordingly, the core serves as a safe storage area for the drug while the shell manages the release speed, providing added stability and supporting sustained delivery. By enabling targeted drug release, this controlled mechanism can help improve treatment outcomes and reduce side effects. Various materials, including polymers, lipids, and inorganic substances create these NPs. Biodegradable polymers, such as poly(lactic-co-glycolic acid) and poly(lactic acid), are popular choices because they offer adjustable degradation rates, which further control how the drug is released. These materials can be tailored for better drug loading, compatibility with the host organism, and specific chemical properties to suit different therapeutic needs. Research into core–shell NPs has been advancing in many therapeutic areas, highlighting their potential for drug delivery innovations. The potential of core–shell NPs to revolutionize drug delivery is not just a possibility but a promising reality that could significantly advance the field of personalized/precision medicine.

24 April 2024 in Zanco Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
Suren Azad RamadhanSuren Azad Ramadhan
Suren Azad Ramadhan
HOHuner K. Omer
Huner K. Omer
Background and objective: Atorvastatin calcium (ATV) has a solubility in aqueous solutions of greater than 0.1 mg/ml to less than 1 mg/ml, which is very slightly soluble. When developing dosage forms for these medications, formulation scientists still face challenges. This study's goal was to use various hydrotropic agents in the formation of solid dispersion-based hydrotropic blends to improve the solubility properties of atorvastatin calcium. Methods: In this study, twenty-two distinct binary, ternary, and quaternary formulations of ATV were prepared by employing five different hydrotropic agents and combining at least two hydrotropic agents in concentrations of 10% and 20% (w/v). Moreover, solid dispersion by the solvent evaporation method and physical mixture-based hydrotropic blends in the ratio of (1:2) have been formulated. The produced formulations were characterized using an FTIR analysis. Results: According to the findings, binary formulations containing 20% (w/v) concentrations of sodium benzoate (SB), sodium salicylate (SS), and resorcinol (R) enhanced the solubility ratio of ATV by 439.31, 689.57, and 106.21 folds, respectively. Furthermore, ternary formulations (FT14) and quaternary formulations (FQ18) resulted in the enhancement of ATV solubility by 938.45 and 995.12 folds, respectively. Ternary solid dispersion demonstrated the highest enhancement in solubility ratio by 87.68 folds and resulted in a higher dissolution rate of ATV than pure samples of the drug. Finally, FTIR analyses excluded any interactions between medications and excipients by showing no noticeable shift in the peaks. Conclusion: Solid dispersion based hydrotropic blends can provide the production of the dosage forms of practically insoluble drugs with a favorable enhancement ratio in solubility.